Latest Development Pipeline News

Lendlease is in advanced talks to form a 50/50 joint venture with Crown Estate, aiming to accelerate capital release and enhance development delivery across its UK portfolio.

Unibail-Rodamco-Westfield unveils a confident 2025-28 strategy targeting robust EBITDA growth, expanding retail media, and increased shareholder returns. The plan balances disciplined capital allocation with ambitious development and licensing initiatives.

PEXA Group’s third-quarter results align with expectations, driven by Australian growth and UK market headwinds. The company reaffirms its FY25 guidance while navigating ongoing business assessments and regulatory milestones.

Tempest Minerals has announced a $1.47 million non-renounceable pro-rata entitlement offer to fund its gold and iron ore projects in Western Australia, offering new shares with free-attaching options to existing shareholders.

Regis Healthcare reveals strong first-half FY25 financial results with rising occupancy and earnings, while gearing up for significant regulatory reforms under the new Aged Care Act effective July 2025.

Boss Energy reports a successful ramp-up to commercial production at its Honeymoon uranium mine, backed by a robust $229 million cash position and promising growth at its US Alta Mesa project.

Strike Energy’s latest seismic surveys reveal promising exploration and appraisal opportunities at Ocean Hill and Kadathinni, reinforcing its dominant position in the Perth Basin gas market.

Brightstar Resources has locked in a US$11.5 million revolving finance facility with Ocean Partners, bolstering working capital to fuel production expansion and exploration across its Western Australian gold projects in 2025.

HMC Capital has unveiled an ambitious plan to grow its assets under management to over $50 billion within the next 3-5 years, supported by strong fundraising and diversified investment verticals. The company’s FY25 outlook remains solid, underpinned by operational growth and strategic initiatives across real estate, digital infrastructure, and energy transition.

GPT Group unveiled a strategic pivot towards co-investment alongside capital partners, reporting resilient 2024 earnings and expanding its retail management platform through key partnerships and asset acquisitions.

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.

GTI Energy reports positive uranium leach test results at its Lo Herma ISR Uranium Project, confirming mineralisation amenable to alkaline in-situ leach with recoveries around 75%. The company’s scoping study is on track for Q2 2025, supported by updated resource estimates and hydrogeological data.